# SODIUM POLYSTYRENE SULFONATE
> **ANDA214912** · Abbreviated New Drug Application (Generic) · Sponsor: LYNE · Approved 2025-06-10
## Drug
- **FDA Application Number:** ANDA214912
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM POLYSTYRENE SULFONATE
- **Generic name:** SODIUM POLYSTYRENE SULFONATE
- **Active ingredients:** SODIUM POLYSTYRENE SULFONATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL, RECTAL
- **Marketing status:** Prescription
- **Sponsor:** LYNE
- **Manufacturer:** Burel Pharmaceuticals, LLC
- **First approval:** 2025-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214912)
---
*MORVS · CC0 1.0*